16th ESPE Connect Webinar – Rare Thyroid Disorders
Date: Thursday 17 October 2024
Time: 16:00 to 17:30 (CEST) | 15:00 to 16:30 (BST)
Webinar Schedule (all times below are CEST):
16:00 - Welcome and introduction
Professor Anne Rochtus (Leuven, Belgium) - ESPE Connect Webinar Convenor
16:05 - Thyroid Hormone Resistance (A & B)
Dr Carla Moran (Dublin, Ireland)
16:25 - MCT8 deficiency
Professor Edward Visser (Rotterdam, The Netherlands)
16:45 - Patient/Parent testimony: Unmet needs in Rare Thyroid Disorders
Speaker TBC
17:05 - Panel Discussion and Q&A for all talks
All faculty - also joining the panel discussion is Dr Krishna Chatterjee (Cambridge, UK)
17:30 - Webinar Close
Speakers
Dr Carla Moran FRCPI PhD
Carla Moran is a Consultant Endocrinologist at the Beacon Hospital in Dublin, St Vincent’s University Hospital, Dublin and is Associate Professor at University College Dublin. Dr Moran has a particular interest in thyroidology, having completed a thyroid fellowship and PhD in Cambridge, UK. Subspecialty areas of expertise include disorders of Thyroid Hormone action (such as Syndromes of Resistance to Thyroid Hormone), investigation of discordant TFTs and drug induced thyroid dysfunction.
Dr Moran has established a referral service for rare thyroid disease in Dublin and continues to perform research. She has published over 70 peer reviewed papers, book chapters and reviews, with a current H-index of 26. Dr Moran regularly contributes to international conferences as an invited speaker, is an invited member of UK & European guideline development committees for thyroid disease and has recently been elected to serve on the Executive Committee of the European Thyroid Association.
Prof Edward Visser
Prof. dr. W. Edward Visser (endocrinologist) is chief of division of Endocrinology at the Erasmus Medical Center (Rotterdam, The Netherlands). He also heads the Erasmus MC Thyroid Center, including the research laboratory and runs general endocrine as well as specialized thyroid clinics.
Prof. Visser has great interest in understanding normal and disordered cellular thyroid hormone signaling. His research group performs translational and clinical studies in this field. Particularly, they are interested in elucidating mechanisms of disease in MCT8 deficiency as well as developing a therapy.
Dr Krishna Chatterjee
Krishna Chatterjee is Professor of Endocrinology at the University of Cambridge and Consultant Physician at Cambridge University Hospitals NHS Foundation Trust. He is Director of the NIHR Cambridge Clinical Research Facility.
His discoveries of genetic disorders of thyroid gland formation, regulation of hormone synthesis and hormone action, have advanced fundamental knowledge of the thyroid axis. His research translates into a clinical service for the diagnosis and management of rare and unusual thyroid disorders, referred from centres worldwide.
